These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 10904847)
1. Hepatitis C virus and cardiomyopathy. Matsumori A Herz; 2000 May; 25(3):249-54. PubMed ID: 10904847 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus from the hearts of patients with myocarditis and cardiomyopathy. Matsumori A; Yutani C; Ikeda Y; Kawai S; Sasayama S Lab Invest; 2000 Jul; 80(7):1137-42. PubMed ID: 10908160 [TBL] [Abstract][Full Text] [Related]
3. [Hepatitis C virus infection and cardiomyopathy]. Matsumori A Nihon Rinsho; 1999 Feb; 57(2):455-63. PubMed ID: 10078023 [TBL] [Abstract][Full Text] [Related]
4. Newer aspects of pathogenesis of heart failure: hepatitis C virus infection in myocarditis and cardiomyopathy. Matsumori A; Sasayama S J Card Fail; 1996 Dec; 2(4 Suppl):S187-94. PubMed ID: 8951578 [TBL] [Abstract][Full Text] [Related]
5. Dilated cardiomyopathy associated with hepatitis C virus infection. Matsumori A; Matoba Y; Sasayama S Circulation; 1995 Nov; 92(9):2519-25. PubMed ID: 7586353 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus and cardiomyopathy. Matsumori A Intern Med; 2001 Feb; 40(2):78-9. PubMed ID: 11300166 [No Abstract] [Full Text] [Related]
7. Hepatitis C virus infection and heart diseases: a multicenter study in Japan. Matsumori A; Ohashi N; Hasegawa K; Sasayama S; Eto T; Imaizumi T; Izumi T; Kawamura K; Kawana M; Kimura A; Kitabatake A; Matsuzaki M; Nagai R; Tanaka H; Hiroe M; Hori M; Inoko H; Seko Y; Sekiguchi M; Shimotohno K; Sugishita Y; Takeda N; Takihara K; Tanaka M; Yokoyama M Jpn Circ J; 1998 May; 62(5):389-91. PubMed ID: 9626910 [TBL] [Abstract][Full Text] [Related]
8. Low prevalence of hepatitis C virus antibodies and RNA in patients with myocarditis and dilated cardiomyopathy. Grumbach IM; Heermann K; Figulla HR Cardiology; 1998 Oct; 90(2):75-8. PubMed ID: 9778541 [TBL] [Abstract][Full Text] [Related]
17. Restricted usage of T cell receptor V alpha-V beta genes in infiltrating cells in the hearts of patients with acute myocarditis and dilated cardiomyopathy. Seko Y; Ishiyama S; Nishikawa T; Kasajima T; Hiroe M; Kagawa N; Osada K; Suzuki S; Yagita H; Okumura K J Clin Invest; 1995 Aug; 96(2):1035-41. PubMed ID: 7635939 [TBL] [Abstract][Full Text] [Related]
18. [Efficiency of immunosuppressive therapy in virus-negative and virus-positive patients with morphologically verified lymphocytic myocarditis]. Blagova OV; Nedostup AV; Kogan EA; Sulimov VA Ter Arkh; 2017; 89(8):57-67. PubMed ID: 28914852 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of hepatitis C and B virus infection in patients with idiopathic dilated cardiomyopathy in Brazil: a pilot study. Reis FJ; Viana M; Oliveira M; Sousa TA; Paraná R Braz J Infect Dis; 2007 Jun; 11(3):318-21. PubMed ID: 17684632 [TBL] [Abstract][Full Text] [Related]
20. Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins. Maisch B; Hufnagel G; Kölsch S; Funck R; Richter A; Rupp H; Herzum M; Pankuweit S Herz; 2004 Sep; 29(6):624-36. PubMed ID: 15912438 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]